These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10996034)

  • 1. Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.
    Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Yoshida H; Matsuno T; Saito M; Sato M
    Immunopharmacology; 2000 Sep; 49(3):363-76. PubMed ID: 10996034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
    Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M
    Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and from untreated bacteria.
    Okamoto M; Oshikawa T; Ohe G; Furuichi S; Nishikawa H; Tano T; Bando T; Yoshida H; Matsubara S; Matsuno T; Saito M; Sato M
    Int Immunopharmacol; 2001 Oct; 1(11):1957-68. PubMed ID: 11606027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
    Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of cytokine-inducing protein of seed extract from Aeginetia indica L., a parasitic plant.
    Okamoto M; Ohe G; Oshikawa T; Nishikawa H; Furuichi S; Bando T; Yoshida H; Sakai T; Himeno K; Sato M; Ohkubo S
    Immunopharmacology; 2000 Sep; 49(3):377-89. PubMed ID: 10996035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
    Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
    J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice.
    Okamoto M; Oshikawa T; Ohe G; Nishikawa H; Furuichi S; Tano T; Moriya Y; Saito M; Sato M
    Int Immunopharmacol; 2001 Sep; 1(9-10):1789-95. PubMed ID: 11562070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432.
    Okamoto M; Kaji R; Kasetani H; Yoshida H; Moriya Y; Saito M; Sato M
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):232-42. PubMed ID: 8334107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
    Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
    J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
    Fujimoto T; Duda RB; Szilvasi A; Chen X; Mai M; O'Donnell MA
    J Immunol; 1997 Jun; 158(12):5619-26. PubMed ID: 9190909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
    Huang XL; Fan Z; Murayama T; Rinaldo C
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
    Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
    J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoteichoic acid-related molecule derived from the streptococcal preparation, OK-432, which suppresses atopic dermatitis-like lesions in NC/Nga mice.
    Horiuchi Y; Bae S; Katayama I; Oshikawa T; Okamoto M; Sato M
    Arch Dermatol Res; 2006 Sep; 298(4):163-73. PubMed ID: 16845523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-α secretion following OK-432 in vitro stimulation of purified human monocytes.
    Olsnes C; Olofsson J; Aarstad HJ
    Scand J Immunol; 2011 Aug; 74(2):114-25. PubMed ID: 21388428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
    Ujiie T
    Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
    Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
    Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha is secreted by monocytes in transit to become macrophages, but not by peripheral blood monocytes, following OK-432 (lyophilized S. pyogenes) stimulation.
    Olsnes C; Stavang H; Olofsson J; Aarstad HJ
    Scand J Immunol; 2007 Dec; 66(6):684-93. PubMed ID: 18021366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro augmentation of human natural killer (NK) cell activity by a streptococcal preparation OK-432 and its extracts, protein M and polysaccharides.
    Wakasugi H; Oshimi K; Kasahara T; Miyata M; Morioka Y
    Int Arch Allergy Appl Immunol; 1982; 67(4):322-8. PubMed ID: 7040254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.